Evidence-Based Medicine Guidelines
Chemotherapy and immunotherapy of malignant mesothelioma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chemotherapy and Immunotherapy of Malignant Mesothelioma." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma.
Chemotherapy and immunotherapy of malignant mesothelioma. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma. Accessed March 12, 2025.
Chemotherapy and immunotherapy of malignant mesothelioma. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma
Chemotherapy and Immunotherapy of Malignant Mesothelioma [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chemotherapy and immunotherapy of malignant mesothelioma
ID - 455327
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455327/all/Chemotherapy_and_immunotherapy_of_malignant_mesothelioma
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
